Hanson McClain Advisors »

Silverback Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.7k 743 11.65
2025-09-30 $8.0k 796 10.05
2025-06-30 $13k 752 17.45
2025-03-31 $11k 743 14.64
2024-12-31 $10k 743 13.55
2024-09-30 $11k 743 14.50
2024-06-30 $865 82 10.55
2024-03-31 $838 82 10.23